Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
60 Cards in this Set
- Front
- Back
Major HLA types
|
A B C D
|
|
B27 associated with
|
Acute anterior uveitis
ankylosing spondylitis Reiter's syndrome |
|
DR4 associated with
|
rheumatoid arthritis
diabetes-insulin dep |
|
DR3 associated with
|
Sjogren's
Graves SLE diabetes- insulin dep |
|
(1) Major systemic APC
(2) Major ocular APC (3) Main ocular phagocytic cell |
(1) macrophage
(2) Langerhans cells -non-(3) macrophage derived PMNs |
|
Importance of Langerhans cells being non-macrophage derived
|
leads to the Ab response that avoids activation of eosinophils, mast cells, basophils, etc. which can harm the epithelium
|
|
Macrophages are not found in the eye?
T or F |
F
found in reduced numbers |
|
Characteristics of macrophages in the eye
|
(1) do NOT produce IL-12 (IFN-gama stimulator to cell killing)
(2)do NOT express CD40 (3)DO express high levels of TGF-B( down regulates inflammatory side) |
|
Tears contain Ig_?
|
IgM
IgG IgA |
|
Major presence of Ab in tears is________ which is produced in the ____________.
|
SIgA
Lacrimal gland |
|
__________reduce the production of SIgA and _______is required for the production of secretory component.
|
Androgens
insulin |
|
Cornea contains lymphatics and vascular supply.
T of F |
False
|
|
Cytokines present in the eye.
|
IL-1
IL-6 IL-8 IL-10 |
|
IL-___ important in that over action results in corneal melting.
|
IL-1
|
|
IL-___ important in that is allows for clearance of herpetic lesions
|
IL-10
|
|
Present of all ocular T-cells and results is ______.
|
FAS ligand
apoptosis |
|
Over action during wound healing results in chronic ulceration.
|
MMPs
IL-1 also elevated |
|
Dry eye causes up regulation of____ need to treat with _____.
|
IL-1
Restasis |
|
NK cells are inactivated in this area. High levels of TGF-B are present of keep ______ out.
|
Anterior chamber
T-cells |
|
Implicated in capsular opacitication post-surgery.
|
TGF-B
|
|
Key immune players in the retina but do NOT express MHCII of produce IL-1.
T-cell down regulated and FAS is present. |
Mueller cells
|
|
MMPs
MMM-9 are indicated in ___________. |
Diabetic Ret.
|
|
Angioenic factor
|
VEGF
(vascular endothelial growth factor) |
|
Antiangiogenic factor
|
PEDF
(pigment epithelium derived factor) |
|
Important in controlling neovascularization.
|
Balance of VEGF and PEDF
|
|
Predominate Ab with 1st exposure until _______ is produced _________ days later.
|
IgM
IgG- produced 7-14 days after |
|
Predominate Ab with 2nd exposure due to _________.
|
IgG due to sensitized B-cells.
IgM same. |
|
Ocular disease associated with Type I (IgE/Mast cell/Basophils)
|
Acute allergic conjunctivitis
|
|
Ocular disease associated with Type II (Ab-dep)
|
Stevens-Johnson syndrome
|
|
Ocular disease associated with Type III (I-C medicated)
|
Arteritis
marginal ulcers |
|
Ocular disease associated with Type IV (cell cytotoxicity mediated)
|
GPC
|
|
A tissue or organ system that has become so specialized in its cellular structure that it is no longer recognized as "self" by normal immune cells and therefore must be shielded from the body's immune mechanisms
|
Immune Privilege
|
|
Examples of ocular structures that have immune privilege
|
A/C
subretinal space RPE vitreous |
|
Lymphatics are present and vascular elements are NOT tight-junctioned in structures of the eye with immune privilege.
T or F |
False
|
|
Venous drainage of the eye forces ________ to the spleen and leaves an __________response instead of an ______________ response.
|
antigens
antibody inflammatory |
|
If an area has immune privilege, an immune response ____________ develop.
|
WILL but with time
|
|
Y402H gene and ________ are strongly correlated (50%).
|
Macular degeneration.
|
|
Y402H gene will be activiated if ________ is mutated.
|
complement factor H (CFH)
|
|
Leads to complement activation and drusen.
|
mutated complement factor H (CFH)
|
|
The CFH protein can be modified by_________ and elevated level of _________.
|
smoking
C-reactive protein (CRP) |
|
Activation of complement causes
|
cell lysis
inflammation |
|
Inflammation and hypoxia cause the release of ________ from BV and disrupts the balance of __________ and leads to ______________
|
VEGF
VEGF/PEDF neovascularization |
|
Complement factor H roles
|
(1) decreases the activity of the alternate complement pathway
(2) bind to heparin (3) bing to C-reactive protein (CRP) (4)bind to appropriate receptors on retina |
|
Spring Allergies
|
flowering grass (bermuda, timothy)
ornamental flowers NOT Pine pollen (too big) |
|
Fall Allergies
|
Ragweed
(NOT Goldenrod which is taller) |
|
Year-round allergies
|
Animal saliva
Dander Dust mites (10% pillow wt if replaced by dust mite droppings each year YUUUCCCKKKKKKKKK) |
|
3 types of Mast Cells
|
(1) Chymase (+)
(2) Tryptase (+) (3) Chymase (+) and Tryptase (+) |
|
Most common Mast cell on ocular surface.
|
Tryptase (+)
|
|
Degranulation of Tryprase (+) causes:
|
(1) degranulation and release of histamine and heparin
(2) chemotactic factors for eopsinphils, leukotrienes, & platelet activating factor (3) mediator in 2 attract more inflammatory cells and enhance degranulation |
|
Mast cell process
|
(1) IgE to antigen
(2) complex links receptors on mast cell (priming) (3)elevate cGMP= degranulation by elevate production of phospholipase A2 (4) begins arachidonic acid cascade |
|
Effect of histamine
|
decrease degranulation by INCREASING cAMP
|
|
Effect of B-adrenergics
|
decrease degranulation by INCREASING cAMP
|
|
Effect of prostaglandins
|
decrease degranulation by INCREASING cAMP via cyclase
|
|
Effect of phosphodiesterase inhibitors
|
STOP conversion of cAMP to 5'AMP
|
|
Effect of alpha-agonist
|
Increase cGMP which increase degranulation
|
|
Effect of cholinergics
|
Increase cGMP which increase degranulation
|
|
Effect of steroids
|
(1) shuts down mRNA production of phosphodiesterase A2
(2) which reduces amt arachidonic acid produced (3) increase cAMP levels and stabilize the cell (4) AA cascade reduced LT & PG & chemotactic factors (5) BV constrict (6) chemotaxis inhibited |
|
Immune function and macrophage activity is reduced by ____________.
|
Steroids
|
|
What is the Conjunctival Challenge?
|
Test by the FDA to determine whether or not a new drug has the ability to combat allergic responses. use of baseline rxn against drug.
|
|
Factors graded on the conjunctival challenge.
|
(1) redness
(2) watering (3) chemosis |